Gene: SLC7A6
Official Full Name: solute carrier family 7 member 6provided by HGNC
Gene Summary: Enables L-lysine:L-arginine antiporter activity and arginine binding activity. Involved in L-arginine transmembrane transport; L-leucine transport; and ornithine transport. Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO33622 | SLC7A6 Knockout cell line (HeLa) | Human | SLC7A6 | 1:3~1:6 | Negative | Online Inquiry |
KO33623 | SLC7A6 Knockout cell line (HCT 116) | Human | SLC7A6 | 1:2~1:4 | Negative | Online Inquiry |
KO33624 | SLC7A6 Knockout cell line (HEK293) | Human | SLC7A6 | 1:3~1:6 | Negative | Online Inquiry |
KO33625 | SLC7A6 Knockout cell line (A549) | Human | SLC7A6 | 1:3~1:4 | Negative | Online Inquiry |
SLC7A6 Gene Knockout Cell Lines are genetically engineered cell lines designed to lack the SLC7A6 gene, which encodes a member of the solute carrier family involved in the transport of amino acids across cell membranes. This product allows researchers to study the physiological and pathological roles of SLC7A6 in various cellular contexts, shedding light on its involvement in processes such as neurotransmitter transport and metabolic regulation.
The primary mechanism of these cell lines involves the disruption of SLC7A6's normal functionality, leading to changes in uptake and transport of specific amino acids. By eliminating the SLC7A6 gene, scientists can investigate downstream effects on cellular metabolism, signaling pathways, and overall cellular health. This knockout approach is particularly valuable in research areas such as neurobiology, metabolic disorders, and cancer biology, where understanding the precise roles of amino acid transport is crucial.
The scientific importance of SLC7A6 Gene Knockout Cell Lines extends to both research and clinical applications. In preclinical studies, these cell lines can be utilized for drug development, screening potential therapeutic agents, and deciphering the consequences of altered amino acid transport in disease states. Furthermore, their use can lead to breakthroughs in personalized medicine by identifying specific metabolic pathways disrupted in patients with various conditions.
What sets SLC7A6 Gene Knockout Cell Lines apart from alternatives is their specificity and reliability. Generated through advanced CRISPR-Cas9 technology, these cell lines offer high efficiency and reproducibility, ensuring that researchers obtain consistent results across multiple experiments. Moreover, these knockout models provide a clearer understanding of SLC7A6’s role, eliminating confounding factors often present in wild-type cells.
For researchers and clinicians dedicated to advancing their work in cellular and molecular biology, SLC7A6 Gene Knockout Cell Lines represent an invaluable resource. With precise gene editing enabling focused exploration of specific biological questions, the value of this product lies in its potential to contribute to significant scientific discoveries and therapeutic advancements.
Our company specializes in providing high-quality, state-of-the-art genetic tools that empower researchers in their quest for knowledge. With our expertise in cell line development, we are committed to supporting scientific innovation and excellence in research applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.